Cargando…

Deficiencies in the Designs and Interventions of COVID-19 Clinical Trials

Detalles Bibliográficos
Autores principales:	Hsiehchen, David, Espinoza, Magdalena, Hsieh, Antony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334919/ https://www.ncbi.nlm.nih.gov/pubmed/32838360 http://dx.doi.org/10.1016/j.medj.2020.06.007

Ejemplares similares

The Cooperative Landscape of Multinational Clinical Trials
por: Hsiehchen, David, et al.
Publicado: (2015)

Multinational teams and diseconomies of scale in collaborative research
por: Hsiehchen, David, et al.
Publicado: (2015)

Prevalence of Female Authors in Case Reports Published in the Medical Literature
por: Hsiehchen, David, et al.
Publicado: (2019)

Representation of Investigators by Gender Among Authors of Phase 3 Oncology Trials Worldwide
por: Muquith, Maishara, et al.
Publicado: (2022)

Political partisanship and mobility restriction during the COVID-19 pandemic
por: Hsiehchen, D., et al.
Publicado: (2020)

Letter on: “An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry – India”
por: Maulik, Mohua, et al.
Publicado: (2020)

Response to the Letter on: “An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry – India”
por: Pillamarapu, Mounika, et al.
Publicado: (2020)

Advanced statistical methods and designs for clinical trials for COVID-19
por: Shan, Guogen, et al.
Publicado: (2021)

Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma
por: Lim, Mir, et al.
Publicado: (2023)

Response to advances statistical methods and designs for clinical trials for COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups
por: Hsiehchen, David, et al.
Publicado: (2021)

Vitamin C and COVID-19: should clinical trials be prioritised for low income settings and vitamin C-deficient populations?
por: Carr, Anitra C., et al.
Publicado: (2023)

Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19
por: Stallard, Nigel, et al.
Publicado: (2020)

Novel Clinical Trial Design for the Study of the Effect of Prone Position on Clinical Outcomes of COVID-19 Patients
por: Yarahmadi, Sajad, et al.
Publicado: (2022)

Enrollment of Pediatric Patients in COVID-19 Interventional Trials
por: Ong, Mei-Sing, et al.
Publicado: (2023)

Transparency, Accessibility, and Variability of US Hospital Price Data
por: Haque, Waqas, et al.
Publicado: (2021)

Deficiencies in Planning Interventional Trial Registration of COVID-19 in China
por: Li, Xiaodan, et al.
Publicado: (2021)

Effects of the COVID-19 Pandemic on Active Non-COVID Clinical Trials
por: Gaudino, Mario, et al.
Publicado: (2020)

Assessment of the Temporal Trajectory of Clinical Trials for COVID-19 Interventions After Highly Publicized Lay and Medical Attention
por: Yehya, Nadir
Publicado: (2021)

Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors
por: Hsieh, Antony, et al.
Publicado: (2020)

Tailoring of the ongoing water, sanitation and hygiene interventions for prevention and control of COVID-19
por: Mushi, Vivian, et al.
Publicado: (2020)

The Impact of COVID-19 on Dermatology Clinical Trials
por: Desai, Sheena, et al.
Publicado: (2021)

Modifications to Communities for Healthy Living trial design resulting from COVID-19
por: Davison, Kirsten K., et al.
Publicado: (2020)

Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2)
por: Knorr, Jack, et al.
Publicado: (2021)

Mild to moderate clinical course of COVID-19 infection in patients with common variable immune deficiency
por: Lesichkova, Spaska, et al.
Publicado: (2023)

Serious vitamin D deficiency in healthcare workers during the COVID-19 pandemic
por: Funaki, Takanori, et al.
Publicado: (2022)

Trends in Hypertension Clinical Trials Focused on Interventions Specific for Black Adults: An Analysis of ClinicalTrials.gov
por: Zheutlin, Alexander R., et al.
Publicado: (2020)

Exclusion of Older Adults in COVID-19 Clinical Trials
por: Abi Jaoude, Joseph, et al.
Publicado: (2020)

Use of sulforaphane in COVID-19: Clinical trials are needed
por: Kow, Chia Siang, et al.
Publicado: (2022)

Alpha-1 Antitrypsin Deficiency and COVID-19 Infection
por: Strassmair, Michael, et al.
Publicado: (2021)

Role of vitamin D deficiency and comorbidities in COVID-19
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2022)

Design and reporting of interventional clinical trials
Publicado: (2022)

Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research
por: Choudhury, Noura J., et al.
Publicado: (2021)

Contribution of Interventional Radiology to the Management of COVID-19 patient
por: Monfardini, Lorenzo, et al.
Publicado: (2020)

Designing of clinical information update system for clinicians on Covid-19: A commentary
por: Ashrafi-Rzi, Hasan, et al.
Publicado: (2020)

Vitamin D and COVID-19: Does a Deficiency Point Towards an Unfavorable Outcome?
por: Bhimani, Sameer, et al.
Publicado: (2020)

Micronutrient deficiencies in patients with COVID-19: how metabolomics can contribute to their prevention and replenishment
por: Tsoukalas, Dimitris, et al.
Publicado: (2020)

Principles for the production and dissemination of recruitment material for three clinical trials of an online intervention
por: Rennick-Egglestone, Stefan
Publicado: (2021)

The application of direct viral cytopathic hypothesis to design drug trials in the battle against COVID-19
por: Ashraf, Mohammad Ali, et al.
Publicado: (2020)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8pu6t78i0tdbgke0g2kckt8olt